NCT03988023View on ClinicalTrials.gov

Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.

PHASE3TerminatedINTERVENTIONAL
Enrollment

1,043

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

July 13, 2021

Study Completion Date

July 13, 2021

Conditions
Severe Osteoarthritis of the Knee
Interventions
BIOLOGICAL

Ampion

4 mL injection of Ampion

DRUG

Saline

Saline solution, 4 mL, single intra-articular injection

Trial Locations (1)

80113

Denver Metro Orthopedics, Englewood

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT03988023 - Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee. | Biotech Hunter | Biotech Hunter